Isomonit (Isosorbide Mononitrate)

Isosorbide mononitrate is converted in the body to nitric oxide, which relaxes vascular smooth muscle through a cyclic GMP pathway. This vasodilation lowers cardiac preload and afterload, decreasing myocardial oxygen demand and relieving anginal symptoms.

The appropriate dose of Isomonit is determined by the prescribing clinician based on the patient’s clinical condition, response, and tolerance. Dosage regimens are individualized and should follow the prescriber’s instructions.

Safety data for isosorbide mononitrate in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To order Isomonit, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Isomonit belongs to the nitrate class, offering a long‑acting nitric‑oxide donor effect. Compared with short‑acting nitrates, it provides more stable plasma levels and fewer dosing fluctuations. Unlike beta‑blockers, it does not affect heart rate, making it suitable for patients where heart‑rate control is not desired.

Isomonit should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in humid or excessively hot environments.

Isomonit is taken orally, usually with a glass of water. It can be taken with or without food, but patients should follow the prescribing clinician’s guidance regarding timing relative to meals to minimize gastrointestinal discomfort.

Serious risks include severe hypotension, syncope, myocardial infarction, life‑threatening arrhythmias, and allergic reactions such as angioedema. Patients should seek immediate medical attention if they experience fainting, chest pain, rapid heartbeat, or signs of an allergic response.

Isomonit is contraindicated in patients with known hypersensitivity to isosorbide mononitrate or any nitrate, those who have taken phosphodiesterase‑5 inhibitors within 24 hours, and individuals with severe hypotension or uncompensated heart failure unless specifically directed by a physician.